Gonorrhea Archive
The listed web pages are archived for historical purposes and are no longer being updated.
- Changes to Gonorrhea and Syphilis Case Definitions: Program ImpactCdc-pdf (January 16, 2014)
- Kidd S, Lee MVC, Maningas E, Komeya A, Kunimoto G, O’Connor N, Katz AR, Wasserman G, Kirkcaldy RD, Whelen AC. Gonococcal susceptibility to cephalosporins—Hawaii, 2003–2011External. Sexually Transmitted Disease 2013;40(9):756–9. AbstractExternal
- Two New Promising Treatment Regimens for Gonorrhea – press release (July 15, 2013)
- What You Need to Know About Gonorrhea – Video by Dr. Monica Patton, Medical Epidemiologist in the Division of STD Prevention at the Centers for Disease Control and Prevention, shares information about how gonorrhea is spread, symptoms and complications of the infection, screening recommendations, and treatment. (April 30, 2013)
- Cephalosporin-Resistant Gonorrhea in North AmericaExternal – JAMA editorial by Robert D. Kirkcaldy, MD, MPH (January 9, 2013)
- Kirkcaldy RD, Zaidi A, del Rio C, Hook EW, Holmes KK, Soge OO, Hall G, Papp J, Bolan G, Weinstock HS. Neisseria gonorrhoeae antibiotic resistance among men who have sex with men, the Gonococcal Isolate Surveillance Project, 2005–2010. Annals of Internal Medicine 2013;158(5):321–328. AbstractExternal
- New Treatment Guidelines for Gonorrhea: Antibiotic ChangeExternal – CDC expert commentary featuring Dr. Robert Kirkcaldy (August 13, 2012)
- Update to CDC’s Sexually Transmitted Diseases Treatment 2010 Guidelines: Oral Cephalosporins No Longer a Recommended Treatment for Gonococcal Infections – MMWR August 10, 2012
- Cephalosporin-Resistant Neisseria gonorrhoeae Public Health Response PlanCdc-pdf (August 9, 2012)
- Audio Podcast – Dr. Robert Kirkcaldy, lead author of the updated gonorrhea treatment guidelines, discusses new gonorrhea treatment recommendations in this three minute podcast. (August 9, 2012)
- Press Release – Media announcement about updated gonorrhea treatment guidelines, includes quotes from NCHHSTP leadership (August 9, 2012)
- Quinolones and the Clinical Laboratory – information from CDC.
-
The Growing Threat of Multidrug-Resistant Gonorrhea – CDC Public Health Grand Rounds – View recording of webinar from May 15, 2012 (May 18, 2012)
- MMWR on CDC Grand Rounds: The Growing Threat of Multidrug-Resistant Gonorrhea (February 14, 2013)
- Cephalosporin Susceptibility Among Neisseria gonorrhoeae Isolates — United States, 2000–2010 – MMWR July 8, 2011 (July 7, 2011)
- Dear Colleague LetterCdc-pdf – azithromycin resistance in Hawaii (May 24, 2011)
- Neisseria gonorrhoeae with Reduced Susceptibility to Azithromycin — San Diego County, California, 2009 – MMWR May 13, 2011 (May 12, 2011)
- Consultation Meeting on Cephalosporin-Resistant Gonorrhea Outbreak Response PlanCdc-pdf (January 20, 2011)
-
Clinic-Based Testing for Rectal and Pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis Infections – MMWR (July 10, 2009)
- Dear Colleague LetterCdc-pdf (July 13, 2009)
-
Availability of Cefixime 400 mg Tablets — United States, April 2008 – MMWR (April 25, 2008)
- Dear Colleague LetterCdc-pdf (April 9, 2008)
- Updated recommended treatment regimens for gonococcal infections and associated conditions – United States, April 2007 (April 12, 2007)
- Increases in Gonorrhea — Eight Western States, 2000–2005 – MMWR (March 16, 2007)
- Expedited Partner Therapy (EPT) (December 2006)
- Notice to Readers: Discontinuation of Spectinomycin – MMWR (April 7, 2006)
- Increases in Fluoroquinolone-Resistant Neisseria gonorrhoeae Among Men Who Have Sex with Men — United States, 2003, and Revised Recommendations for Gonorrhea Treatment, 2004 – MMWR (April 30, 2004)
- STD Surveillance 2002 – GonorrheaCdc-pdf (November 20, 2003)
- Control of Neisseria gonorrhoeae Infection in the United StatesCdc-pdf – Report of an External Consultants’ Meeting. (April 9, 2003)
- Notice to Readers: Discontinuation of Cefixime Tablets – MMWR (November 22, 2002)
- Increases in Fluoroquinolone-Resistant Neisseria gonorrhoeae — Hawaii and California, 2001 – MMWR. (November 22, 2002)
- Screening Tests to Detect Chlamydia trachomatis and Neisseria gonorrhoeae Infections – 2002 – MMWR (October 18, 2002)
- Notice to Readers: Recall of LCx® Neisseria gonorrhoeae Assay and Implications for Laboratory Testing for N. gonorrhoeae and Chlamydia trachomatis – MMWR. (August 19, 2002)
- Notice to Readers: Update on Spectinomycin Availability in the United States – MMWR. (August 3, 2001)
- Notice to Readers: Shortage of Spectinomycin – MMWR (June 8, 2001)
- Tracking the Hidden Epidemics – Trends 2000Cdc-pdf – 1999 data (October 23,2000)
- Fluoroquinolone-Resistance in Neisseria gonorrhoeae, Hawaii, 1999, and Decreased Susceptibility to Azithromycin in N. gonorrhoeae, Missouri, 1999 – MMWR (September 22, 2000)
- Gonorrhea – United States 1998 – MMWR (June 23, 2000)
- Alcohol Policy and Sexually Transmitted Disease Rates — United States, 1981 – 1995 – MMWR (April 28, 2000)
- High Prevalence of Chlamydial and Gonococcal Infection in Women Entering Jails and Juvenile Detention Centers — Chicago, Birmingham, and San Francisco, 1998 – MMWR (September 17, 1999)
- Increase in Unsafe Sex and Rectal Gonorrhea – MMWR. (January 29, 1999)
- Fluoroquinolone-Resistant Neisseria gonorrhoeae — San Diego, California, 1997 – MMWR (May 29, 1998)
- Gonorrhea Among Men Who Have Sex with Men — Selected Sexually Transmitted Diseases Clinics, 1993-1996 – MMWR (September 26, 1997)
- Fluoroquinolone Resistance in Neisseria gonorrhoeae — Colorado and Washington, 1995 – MMWR (October 20, 1995)
Page last reviewed: November 27, 2018